{"entity":{"type":"insider","cik":"0001600359","url":"/insider/0001600359","json_url":"/insider/0001600359.json","name":"Hillan Kenneth J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":9,"first":"2016-03-21","last":"2022-08-25","span_basis":"filed_date"},"name_variants":[{"name":"Hillan Kenneth J.","source":"filing","n_filings":9,"first_seen":"2016-03-21","last_seen":"2022-08-25"}],"transactions":[{"id":6729548,"accession":"0001209191-22-047540","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-047540","line_url":"/filing/0001209191-22-047540#line-1","is_derivative":false,"issuer_cik":"0001600359","issuer_name":"23andMe Holding Co.","issuer_ticker":"ME","issuer_name_source":null,"issuer_url":"/issuer/0001600359","owner_cik":"0001600359","owner_name":"Hillan Kenneth J.","owner_display_name":"Hillan Kenneth J.","owner_url":"/insider/0001600359","role":"Officer (Chief Therapeutics Officer)","role_mark":"O","role_mark_label":"Officer (Chief Therapeutics Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Therapeutics Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8753.0,"shares_display":"8,753","price_per_share":3.64,"price_display":"3.64","price_state":"stated","total_value":31860.92,"total_display":"31,860.92","total_whole":"31,861","shares_owned_after":196083.0,"shares_owned_after_display":"196,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-24","filed_date":"2022-08-25","scope":"insider"},{"id":6735567,"accession":"0001140361-18-030423","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-030423","line_url":"/filing/0001140361-18-030423#line-2","is_derivative":false,"issuer_cik":"0001301501","issuer_name":"Achaogen Inc","issuer_ticker":"AKAO","issuer_name_source":null,"issuer_url":"/issuer/0001301501","owner_cik":"0001600359","owner_name":"Hillan Kenneth J.","owner_display_name":"Hillan Kenneth J.","owner_url":"/insider/0001600359","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":744.0,"shares_display":"744","price_per_share":9.59,"price_display":"9.59","price_state":"stated","total_value":7134.96,"total_display":"7,134.96","total_whole":"7,135","shares_owned_after":115401.0,"shares_owned_after_display":"115,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-26","filed_date":"2018-06-28","scope":"insider"},{"id":6310542,"accession":"0001140361-18-013721","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-013721","line_url":"/filing/0001140361-18-013721#line-1","is_derivative":false,"issuer_cik":"0001301501","issuer_name":"Achaogen Inc","issuer_ticker":"AKAO","issuer_name_source":null,"issuer_url":"/issuer/0001301501","owner_cik":"0001600359","owner_name":"Hillan Kenneth J.","owner_display_name":"Hillan Kenneth J.","owner_url":"/insider/0001600359","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2735.0,"shares_display":"2,735","price_per_share":11.74,"price_display":"11.74","price_state":"stated","total_value":32108.9,"total_display":"32,108.90","total_whole":"32,109","shares_owned_after":95151.0,"shares_owned_after_display":"95,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-13","filed_date":"2018-03-15","scope":"insider"},{"id":6874340,"accession":"0001140361-18-009969","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-009969","line_url":"/filing/0001140361-18-009969#line-1","is_derivative":false,"issuer_cik":"0001301501","issuer_name":"Achaogen Inc","issuer_ticker":"AKAO","issuer_name_source":null,"issuer_url":"/issuer/0001301501","owner_cik":"0001600359","owner_name":"Hillan Kenneth J.","owner_display_name":"Hillan Kenneth J.","owner_url":"/insider/0001600359","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4606.0,"shares_display":"4,606","price_per_share":10.67,"price_display":"10.67","price_state":"stated","total_value":49146.02,"total_display":"49,146.02","total_whole":"49,146","shares_owned_after":97886.0,"shares_owned_after_display":"97,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-21","filed_date":"2018-02-23","scope":"insider"},{"id":4994098,"accession":"0001140361-17-012435","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-012435","line_url":"/filing/0001140361-17-012435#line-1","is_derivative":false,"issuer_cik":"0001301501","issuer_name":"Achaogen Inc","issuer_ticker":"AKAO","issuer_name_source":null,"issuer_url":"/issuer/0001301501","owner_cik":"0001600359","owner_name":"Hillan Kenneth J.","owner_display_name":"Hillan Kenneth J.","owner_url":"/insider/0001600359","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3079.0,"shares_display":"3,079","price_per_share":26.58,"price_display":"26.58","price_state":"stated","total_value":81839.82,"total_display":"81,839.82","total_whole":"81,840","shares_owned_after":98422.0,"shares_owned_after_display":"98,422","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-14","filed_date":"2017-03-16","scope":"insider"},{"id":4171728,"accession":"0001140361-17-008924","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-008924","line_url":"/filing/0001140361-17-008924#line-1","is_derivative":false,"issuer_cik":"0001301501","issuer_name":"Achaogen Inc","issuer_ticker":"AKAO","issuer_name_source":null,"issuer_url":"/issuer/0001301501","owner_cik":"0001600359","owner_name":"Hillan Kenneth J.","owner_display_name":"Hillan Kenneth J.","owner_url":"/insider/0001600359","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1696.0,"shares_display":"1,696","price_per_share":22.76,"price_display":"22.76","price_state":"stated","total_value":38600.96,"total_display":"38,600.96","total_whole":"38,601","shares_owned_after":61501.0,"shares_owned_after_display":"61,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-21","filed_date":"2017-02-23","scope":"insider"},{"id":5361352,"accession":"0001140361-17-003547","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-003547","line_url":"/filing/0001140361-17-003547#line-1","is_derivative":false,"issuer_cik":"0001301501","issuer_name":"Achaogen Inc","issuer_ticker":"AKAO","issuer_name_source":null,"issuer_url":"/issuer/0001301501","owner_cik":"0001600359","owner_name":"Hillan Kenneth J.","owner_display_name":"Hillan Kenneth J.","owner_url":"/insider/0001600359","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1431.0,"shares_display":"1,431","price_per_share":16.78,"price_display":"16.78","price_state":"stated","total_value":24012.18,"total_display":"24,012.18","total_whole":"24,012","shares_owned_after":63197.0,"shares_owned_after_display":"63,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-26","filed_date":"2017-01-30","scope":"insider"},{"id":3183633,"accession":"0001140361-16-069150","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-069150","line_url":"/filing/0001140361-16-069150#line-1","is_derivative":false,"issuer_cik":"0001416792","issuer_name":"Relypsa Inc","issuer_ticker":"RLYP","issuer_name_source":null,"issuer_url":"/issuer/0001416792","owner_cik":"0001600359","owner_name":"Hillan Kenneth J.","owner_display_name":"Hillan Kenneth J.","owner_url":"/insider/0001600359","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1013.0,"shares_display":"1,013","price_per_share":19.3115,"price_display":"19.31","price_state":"stated","total_value":19562.5495,"total_display":"19,562.55","total_whole":"19,563","shares_owned_after":1237.0,"shares_owned_after_display":"1,237","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-07","filed_date":"2016-06-08","scope":"insider"},{"id":2330920,"accession":"0001140361-16-058613","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-058613","line_url":"/filing/0001140361-16-058613#line-1","is_derivative":false,"issuer_cik":"0001301501","issuer_name":"Achaogen Inc","issuer_ticker":"AKAO","issuer_name_source":null,"issuer_url":"/issuer/0001301501","owner_cik":"0001600359","owner_name":"Hillan Kenneth J.","owner_display_name":"Hillan Kenneth J.","owner_url":"/insider/0001600359","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3572.0,"shares_display":"3,572","price_per_share":3.22,"price_display":"3.22","price_state":"stated","total_value":11501.84,"total_display":"11,501.84","total_whole":"11,502","shares_owned_after":61628.0,"shares_owned_after_display":"61,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-17","filed_date":"2016-03-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001804591","name":"23andMe Holding Co.","url":"/issuer/0001804591","role":"Officer (Chief Therapeutics Officer)","n_filings":1,"first_seen":"2022-08-25","last_seen":"2022-08-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001301501","name":"Achaogen Inc","url":"/issuer/0001301501","role":"Director, Officer","n_filings":7,"first_seen":"2016-03-21","last_seen":"2018-06-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001416792","name":"Relypsa Inc","url":"/issuer/0001416792","role":"Director","n_filings":1,"first_seen":"2016-06-08","last_seen":"2016-06-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001600359","retrieved_at":"2026-08-22T06:46:02+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}